DSE yields 357.85% · JNJ yields 2.14%● Live data
📍 DSE pulled ahead of the other in Year 1
Combined, DSE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DSE + JNJ for your $10,000?
Duff & Phelps Select MLP and Midstream Energy Fund Inc. (the Fund), formerly Duff & Phelps Select Energy MLP Fund Inc., is a non-diversified, closed-end management investment company. The Fund invests at least 80% of its managed assets in energy master limited partnerships (MLPs) and midstream energy companies that are not organized as MLPs. The Fund may invest up to 20% of its managed assets in securities of issuers either in the energy sector and that are not MLPs or that produce products that are primarily for the use of companies in the energy sector (such as sand miners, certain chemical companies and coking coal processors). The Fund invests in midstream energy companies that includes entities that gather, process, market and transport energy assets, such as crude oil, natural gas, refined products, and natural gas liquids. Virtus Alternative Investment Advisers, Inc. is the investment advisor to the Fund. Duff & Phelps Investment Management Co. is the sub advisor for the Fund.
Full DSE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.